VTR:NYE-Ventas, Inc

COMMON STOCK | REIT - Healthcare Facilities | NYE

Last Closing Price

USD 71.99

Change

-0.67 (-0.92)%

Market Cap

USD 1.30B

Volume

1.50M

Average Target Price

USD 66.59 (-7.50%)
Average Analyst Rating

Verdict

STA Verdict

Verdict

About

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of senior housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to “Ventas” or the “Company” mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted.

Market Stats

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-08-23 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GEO The GEO Group, Inc

-0.68 (-3.90%)

USD 2.11B 13.50 11.83
LTC LTC Properties, Inc

-0.70 (-1.41%)

USD 1.96B 18.48 19.21
WELL Welltower Inc

-1.15 (-1.29%)

USD 1.67B 59.11 23.99
HTA Healthcare Trust of America, I..

-0.41 (-1.46%)

USD 1.48B 27.09 20.76
UHT Universal Health Realty Income..

-2.47 (-2.55%)

USD 1.33B 76.98 28.27
CHCT Community Healthcare Trust Inc..

-0.90 (-2.08%)

USD 0.85B 325.56 28.26
GMRE-PA Global Medical REIT Inc

-0.04 (-0.15%)

USD 0.43B 80.49 31.63
OHI Omega Healthcare Investors, In..

+0.21 (+0.52%)

USD 0.11B 31.66 17.52
HR Healthcare Realty Trust Incorp..

-0.57 (-1.73%)

USD -38,929,408.00 136.64 23.24
MPW Medical Properties Trust, Inc

-0.18 (-0.97%)

USD -337,977,344.00 7.24 19.50

ETFs Containing VTR

Symbol Name Weight Mer Price(Change) Market Cap
OLD The Long-Term Care ETF 13.56 % 0.50 %

-0.14 (-0.46%)

USD 0.02B
REZ iShares Residential Real .. 6.30 % 0.48 %

-0.83 (-1.05%)

USD 0.47B
ICF 4.12 % 0.34 %

N/A

N/A
RWR SPDR Dow Jones REIT ETF 3.57 % 0.25 %

-1.62 (-1.58%)

USD 2.54B
SCHH Schwab U.S. REIT ETF 3.57 % 0.07 %

-0.76 (-1.65%)

USD 5.45B
EWRE Invesco S&P 500 Equal Wei.. 3.17 % 0.40 %

-0.56 (-1.79%)

USD 0.05B
WREI Invesco Wilshire US REIT .. 3.09 % 0.32 %

N/A

USD 0.01B
FRI First Trust S&P REIT Inde.. 2.77 % 0.50 %

-0.36 (-1.39%)

USD 0.15B
HIPS GraniteShares HIPS US Hig.. 2.77 % 0.70 %

-0.29 (-1.76%)

USD 7.61M
USRT iShares Core U.S. REIT ET.. 2.56 % 0.08 %

-0.78 (-1.44%)

USD 1.44B
RWO SPDR Dow Jones Global Rea.. 2.07 % 0.50 %

-0.55 (-1.08%)

USD 2.27B
REET iShares Global REIT ETF 1.82 % 0.14 %

-0.27 (-0.98%)

USD 1.58B
FFR First Trust FTSE EPRA/NAR.. 1.52 % 0.60 %

-0.39 (-0.81%)

USD 0.05B
JKI iShares Morningstar Mid-C.. 1.34 % 0.30 %

-2.83 (-1.84%)

USD 0.46B
PXMV Invesco S&P MidCap Va.. 1.24 % 0.39 %

N/A

USD 0.05B
DRN Direxion Daily MSCI Real .. 0.00 % 1.09 %

-1.22 (-4.28%)

USD 0.05B

Market Performance

  Market Performance vs.
Industry/Classification (REIT - Healthcare Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.87% 77% C+ 84% B
Dividend Return 2.71% 23% F 70% C-
Total Return 25.58% 69% D+ 84% B
Trailing 12 Months  
Capital Gain 21.58% 54% F 91% A-
Dividend Return 5.35% 69% D+ 81% B-
Total Return 26.93% 54% F 92% A-
Trailing 5 Years  
Capital Gain 9.74% 36% F 63% D
Dividend Return 23.45% 18% F 76% C
Total Return 33.19% 27% F 68% D+
Average Annual (5 Year Horizon)  
Capital Gain -1.20% 15% F 34% F
Dividend Return 4.85% 38% F 79% C+
Total Return 3.65% 15% F 46% F
Risk Return Profile  
Volatility (Standard Deviation) 17.54% 54% F 45% F
Risk Adjusted Return 20.82% 15% F 38% F
Market Capitalization 1.30B 64% D 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(REIT - Healthcare Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 52.20 50% F 11% F
Price/Book Ratio 2.49 50% F 33% F
Price / Cash Flow Ratio 19.60 50% F 20% F
EV/EBITDA 20.84 50% F 19% F
Management Effectiveness  
Return on Equity 4.62% 36% F 39% F
Return on Invested Capital 3.60% 43% F 32% F
Return on Assets 2.49% 57% F 47% F
Debt to Equity Ratio 105.07% 36% F 34% F
Technical Ratios  
Short Ratio 3.22 77% C+ 43% F
Short Percent 2.24% 100% A+ 77% C+
Beta 0.26 71% C- 80% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector